ATLANTA, GA--(MARKET WIRE)--Jul 17, 2007 -- AtheroGenics, Inc. (NasdaqGM:AGIX - News), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it will release its second quarter 2007 financial results on Thursday, July 26, 2007, before the U.S. financial markets open.
